Xerostomia management in the head and neck radiation patient.
Haveman
Carl
C
Department of General Dentistry, University of Texas Health Science Center at San Antonio Dental School, San Antonio, Texas, USA.
Huber
Michaell
M
D002180:Candidiasis, Oral / Q000188:drug therapy / Q000209:etiology; D002327:Cariostatic Agents / Q000627:therapeutic use; D016371:Cranial Irradiation / Q000009:adverse effects*; D003731:Dental Caries / Q000209:etiology / Q000517:prevention & control*; D005459:Fluorides / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D018721:Muscarinic Agonists / Q000627:therapeutic use; D009910:Oral Hygiene; D012464:Saliva, Artificial; D013268:Stimulation, Chemical; D014987:Xerostomia / Q000150:complications / Q000209:etiology* / Q000628:therapy*
D002327:Cariostatic Agents; D018721:Muscarinic Agonists; D012464:Saliva, Artificial; D005459:Fluorides